Treatment resistant adolescent depression with upper airway resistance syndrome treated with rapid palatal expansion: A case report

Journal of Medical Case Reports

Volumn 6, Issue , 2012, Pages

  Miller, Paul ^a   Iyer, Mala ^a   Gold, Avram R ^b  

^a Stony Brook University Sleep Disorders Center ^*  (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL FOLATE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CETIRIZINE; ESOMEPRAZOLE; FLUOXETINE; LAMOTRIGINE; LITHIUM; METFORMIN; QUETIAPINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VENLAFAXINE;

ADOLESCENT; ADOLESCENT DISEASE; ANXIETY DISORDER; APNEA; ARTICLE; CASE REPORT; ELECTROCONVULSIVE THERAPY; FATIGUE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERGLYCEMIA; INSOMNIA; MALE; NOSE ALLERGY; ORAL SURGERY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RAPID PALATAL EXPANSION; SOMNOLENCE; SYMPTOM; TREATMENT RESISTANT DEPRESSION; UPPER AIRWAY RESISTANCE SYNDROME;

EID: 84870319101     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-6-415     Document Type: Article

References (15)

1. Treatment-resistant depression in adolescents: review and updates on clinical management. Maalouf FT, Atwi M, Brent DA, Depress Anxiety 28 946 954
2. Rapid maxillary expansion in children with obstructive sleep apnea syndrome. Pirelli P, Saponara M, Guilleminault C, Sleep 2004 27 761 766 15283012 (Pubitemid 38823374)
3. Treatment of obstructive sleep apnea syndrome by rapid maxillary expansion. Cistulli PA, Palmisano RG, Poole MD, Sleep 1998 21 831 835 9871945 (Pubitemid 29006523)
4. Functions of sleep architecture and the concept of protective fields. Voss U, Rev Neurosci 2004 15 33 46 15046198 (Pubitemid 38868411)
5. Health-related quality of life and depressive symptoms in children with suspected sleep-disordered breathing. Crabtree VM, Varni JW, Gozal D, Sleep 2004 27 1131 1138 15532207 (Pubitemid 39331085)
6. Sleep disordered breathing and depression among U.S. adults: National Health and Nutrition Examination Survey, 2005-2008. Wheaton AG, Perry GS, Chapman DP, Croft JB, Sleep 2012 35 461 467 22467983
7. del Campo Matías F, Ruiz Albi T, Zamarrón Sanz C, Upper Airway Resistance Syndrome-A Twenty-Five Years Experience, Sleep Disorders, Idzikowski C, 2012 InTech, Available from: http://www.intechopen.com/books/ sleep-disorders/upper-airway-resistance-syndrome-a-twenty-five-years-experience
8. The symptoms and signs of upper airway resistance syndrome: a link to the functional somatic syndromes. Gold AR, Dipalo F, Gold MS, O'Hearn D, Chest 2003 123 87 95 10.1378/chest.123.1.87 12527607 (Pubitemid 36126718)
9. Silent upper airway resistance syndrome: prevalence in a mixed military population. Kristo DA, Lettieri CJ, Andrada T, Taylor Y, Eliasson AH, Chest 2005 127 1654 1657 10.1378/chest.127.5.1654 15888842 (Pubitemid 46218791)
10. The pharyngeal critical pressure. The whys and hows of using nasal continuous positive airway pressure diagnostically. Gold AR, Schwartz AR, Chest 1996 110 1077 1088 10.1378/chest.110.4.1077 8874271 (Pubitemid 26347629)
11. Functional somatic syndromes, anxiety disorders and the upper airway: a matter of paradigms. Gold AR, Sleep Med Rev 2011 15 389 401 10.1016/j.smrv.2010. 11.004 21295503
12. Review of periodic limb movement and restless leg syndrome. Natarajan R, J Postgrad Med 2010 56 157 162 10.4103/0022-3859.65284 20622400
13. Mechanisms of antidepressant action: an integrated dopaminergic perspective. Porcelli S, Drago A, Fabbri C, Serretti A, Prog Neuropsychopharmacol Biol Psychiatry 2011 35 1532 1543 10.1016/j.pnpbp.2011.03. 005 21402119
14. Dopamine in amygdala gates limbic processing of aversive stimuli in humans. Kienast T, Hariri AR, Schlagenhauf F, Wrase J, Sterzer P, Buchholz HG, Smolka MN, Gründer G, Cumming P, Kumakura Y, Bartenstein P, Dolan RJ, Heinz A, Nat Neurosci 2008 11 1381 1382 10.1038/nn.2222 18978778
15. Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy. Strober M, Rao U, DeAntonio M, Liston E, State M, Amaya-Jackson L, Latz S, Biol Psychiatry 1998 43 335 338 10.1016/S0006-3223(97)00205-9 9513748 (Pubitemid 28137625)